SCHEMBL29653673

SCHEMBL29653673

C#Cc1cccc(Nc2c(C#N)cnc3cc(OCC)c(NC(=O)/C=C/CN(C)C)cc23)c1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.82
▸ ERBB2 P04626 19/20 0.82
▸ STK25 O00506 1/20 0.73
▸ CIT O14578 1/20 0.73
▸ CHEK1 O14757 1/20 0.73
▸ GAK O14976 1/20 0.73
▸ DAPK3 O43293 1/20 0.73
▸ JAK2 O60674 1/20 0.73
▸ STK17B O94768 1/20 0.73
▸ STK10 O94804 1/20 0.73
▸ MAP4K4 O95819 1/20 0.73
▸ ABL1 P00519 1/20 0.73
▸ LCK P06239 1/20 0.73
▸ FYN P06241 1/20 0.73
▸ FES P07332 1/20 0.73
▸ CSF1R P07333 1/20 0.73
▸ YES1 P07947 1/20 0.73
▸ LYN P07948 1/20 0.73
▸ MET P08581 1/20 0.73
▸ HCK P08631 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29501005 1.00 EGFR (0.82) EGFRERBB2STK25CITCHEK1
SCHEMBL29670930 1.00 EGFR (0.82) EGFRERBB2STK25CITCHEK1
SCHEMBL2132745 1.00 EGFR (0.82) EGFRERBB2STK25CITCHEK1
SCHEMBL29780816 1.00 EGFR (0.82) EGFRERBB2STK25CITCHEK1
SCHEMBL2132756 1.00 EGFR (0.82) EGFRERBB2STK25CITCHEK1
Maleic Acid SCHEMBL23420360 0.97 EGFR (0.78) EGFRERBB2STK25CITCHEK1
Maleic Acid SCHEMBL29420770 0.97 EGFR (0.78) EGFRERBB2STK25CITCHEK1
Maleic Acid SCHEMBL29780804 0.97 EGFR (0.78) EGFRERBB2STK25CITCHEK1
Maleic Acid SCHEMBL23420362 0.97 EGFR (0.78) EGFRERBB2STK25CITCHEK1
Maleic Acid SCHEMBL29500961 0.97 EGFR (0.78) EGFRERBB2STK25CITCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111875539-B Preparation method of EGFR (epidermal growth factor receptor) molecular targeted antitumor drug 苏中药业集团股份有限公司 2022-06-21 — — CN claimed
CN-114605321-A Impurities of substituted butene amide raw material and preparation product and analysis method thereof 苏中药业集团股份有限公司 2022-06-10 — — CN claimed
CN-113493414-B Deuterated substituted butenamide and preparation method and application thereof 苏中药业集团股份有限公司 2024-09-27 — — CN disclosed
CN-113493413-B Substituted butenamide-N-oxide and preparation method and application thereof 苏中药业集团股份有限公司 2024-03-26 — — CN disclosed
CN-111875539-B Preparation method of EGFR (epidermal growth factor receptor) molecular targeted antitumor drug 苏中药业集团股份有限公司 2022-06-21 — — CN disclosed
CN-111875539-B Preparation method of EGFR (epidermal growth factor receptor) molecular targeted antitumor drug 苏中药业集团股份有限公司 2022-06-21 — — CN disclosed
CN-114605321-A Impurities of substituted butene amide raw material and preparation product and analysis method thereof 苏中药业集团股份有限公司 2022-06-10 — — CN disclosed
Send feedback